Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check6 days agoChange DetectedExpanded global study locations with many new sites across the United States, Canada, Europe, Australia, and other regions; several existing locations have been removed.SummaryDifference3%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision history updated: added Revision: v3.3.1 and removed Revision: v3.2.0; this change does not affect the study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoval of the government funding status notice that warned about potential delays and operating status updates on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedNo additions or deletions were detected; the study details page content remains unchanged.SummaryDifference0.2%

- Check85 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.